Key result
Patients with chemotherapy-induced cardiomyopathy undergoing advanced heart failure therapies such as mechanical circulatory support or heart transplantation have similar survival outcomes compared to those with other cardiomyopathies.
Advanced heart failure therapies such as mechanical circulatory support and heart transplantation are viable and effective options for patients with chemotherapy-induced cardiomyopathy, yielding survival rates comparable to other heart failure etiologies.
May support advanced therapies in chemotherapy-induced cardiomyopathy; leaves open prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ayub‐Ferreira et al. (2022) conducted a review in Advanced Heart Failure and Chemotherapy-induced Cardiomyopathy. Mechanical circulatory support and heart transplantation vs. Other cardiomyopathies was evaluated. Patients with chemotherapy-induced cardiomyopathy undergoing advanced heart failure therapies such as mechanical circulatory support or heart transplantation have similar survival outcomes compared to those with other cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: